📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-19 13:21
364 analysed today
364
Today
136,372
All-time analysed
40,432
Positive
6,316
Negative
81,696
Neutral
7,860
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
14 announcements match the current filters (relevance ≥ 5).
Galaxy Surfactants Signs Partnership Growth Charter with Unilever Extending 45-Year Tie-Up
Galaxy Surfactants Ltd. has signed a Partnership Growth Charter with global FMCG major Unilever, marking a new phase in their 45-year relationship. The charter serves as a strategic framework to accelerate new chemistries, next-generation surfactant technologies, and bio-based, lower-carbon alternatives. While the filing does not disclose specific contract values or volume commitments, Unilever represents a core customer in the home and personal care segment. Against Galaxy's TTM revenue of ₹5,752 Cr, this agreement reinforces long-term customer stickiness and collaborative R&D pipeline visibility.
Confidence: HIGH
What changedFormalized an innovation and supply resilience growth charter with Unilever to co-develop sustainable and next-gen surfactant chemistries.
Why it mattersDeepens engagement with one of Galaxy's key global FMCG clients and positions the company as a preferred supplier for sustainable, low-carbon surfactant technologies.
Relationship tenure: 45-yearTTM Revenue (Context): ₹5752 CrDeal/Charter commercial value: not disclosed
📅 Short termPositive sentiment indicator demonstrating strong multi-decade client retention, though no immediate impact on quarterly revenue run-rates is quantified.
📈 Long termEnhances long-term competitive moat in specialty green surfactants, ensuring sustained volume allocation and joint technology leadership as FMCG brands transition to bio-based inputs.
⚠ Risk flags
- No specific financial or volume commitments disclosed
- Client concentration exposure to major global FMCG players
Key Highlights
Signed a Partnership Growth Charter with Unilever, expanding their 45-year longstanding relationship
Focuses on next-generation surfactant technologies, bio-based alternatives, and lower-carbon chemistries
Integrates Galaxy's surfactant science with Unilever's formulation and consumer innovation capabilities
Commercial deal value and volume commitments: not disclosed
👀 What to Watch
Track upcoming quarterly management commentaries for any guidance on capital expenditure or revenue share from new bio-based chemistries co-developed under this framework.
₹252.5 Cr Record EBITDA: Galaxy Surfactants Q1 FY27 PAT Jumps 108.7% YoY
Galaxy Surfactants reported its highest-ever quarterly EBITDA of ₹252.5 Cr for Q1 FY27, an 86.9% YoY increase. Revenue grew 38.5% YoY to ₹1,785.2 Cr, driven by a return to double-digit volume growth in India and sustained momentum in Specialty Care. Profitability metrics improved sharply, with EBITDA per Metric Tonne (MT) rising to ₹35,458 from ₹20,009 in the previous year. Despite geopolitical headwinds in the AMET region causing a low-single-digit volume decline, the company saw a strong sequential recovery in that market.
Confidence: HIGH
What changedGalaxy Surfactants achieved record-high profitability and significant margin expansion (14.1% vs 9.0% TTM) following a period of margin pressure in FY26.
Why it mattersThe results demonstrate strong pricing power and the successful execution of a high-margin Specialty Care strategy, which has significantly boosted the bottom line despite global supply chain disruptions.
Q1 FY27 Revenue: ₹1,785.2 CrQ1 FY27 EBITDA: ₹252.5 CrEBITDA Margin: 14.1%EBITDA per MT: ₹35,458Revenue vs TTM Revenue: 34.01%PAT vs TTM PAT: 62.13%
📅 Short termThe stock is likely to react positively to the record-breaking EBITDA and sharp margin improvement which significantly exceeded recent quarterly averages.
📈 Long termThe structural shift toward Specialty Care and recovery in Tier-1 customer demand suggests a higher sustainable earnings base for the company over the coming years.
⚠ Risk flags
- Geopolitical instability in the AMET region impacting the Egypt subsidiary
- Feedstock price fluctuations
- Global supply chain and freight cost volatility
Key Highlights
Highest-ever quarterly EBITDA of ₹252.5 Cr, representing a 107.1% sequential increase from Q4 FY26.
PAT more than doubled YoY to ₹165.9 Cr, compared to ₹79.5 Cr in Q1 FY26.
EBITDA per Metric Tonne (MT) surged 77% YoY to ₹35,458, reflecting a significantly improved product mix.
India region returned to double-digit volume growth, while Specialty Care sustained international momentum.
Consolidated revenue of ₹1,785.2 Cr for the quarter represents approximately 34% of the total TTM revenue.
👀 What to Watch
Watch for the sustainability of the elevated EBITDA/MT levels and the volume recovery trajectory in the AMET (Egypt/West Asia) region amidst ongoing geopolitical tensions.
109% PAT Growth in Q1 FY27: Galaxy Surfactants Reports Strong Margin Recovery
Galaxy Surfactants reported a robust Q1 FY27 with consolidated revenue growing 39.4% YoY to ₹1,781.9 Cr. Net profit surged 108.7% YoY to ₹165.9 Cr, driven by a significant expansion in EBITDA margins to 14.1% from 10.5% in the previous year. Volume growth was led by the India market (double-digit), while the AMET region saw a slight decline due to geopolitical issues. EBITDA per tonne reached a high of ₹35,458, reflecting better product mix and pricing discipline despite volatile raw material costs.
Confidence: HIGH
What changedThe company transitioned from a period of margin pressure to a high-margin environment in Q1 FY27, with EBITDA growing 87% YoY.
Why it mattersThe results demonstrate the company's ability to pass on raw material costs and benefit from a favorable product mix in Specialty Care, which is critical for long-term profitability.
Q1 FY27 Revenue: ₹1,781.9 CrQ1 FY27 PAT: ₹165.9 CrEBITDA Margin: 14.1%EBITDA per MT: ₹35,458Revenue vs TTM Revenue: ~34%
📅 Short termPositive sentiment is expected in the coming weeks due to the sharp recovery in margins and PAT exceeding recent quarterly averages.
📈 Long termStructural focus on Specialty Care and the recovery in India volumes are positive indicators for long-term growth, though geopolitical risks in Egypt remain a factor.
⚠ Risk flags
- Geopolitical disruptions in AMET region impacting Egypt subsidiary
- Volatility in Fatty Alcohol prices
- Rising crude-linked feedstock costs
Key Highlights
Consolidated PAT grew 108.7% YoY to ₹165.9 Cr for the quarter ended June 30, 2026
EBITDA per Metric Tonne (MT) improved significantly to ₹35,458/MT
India volumes returned to double-digit growth after nearly two years of stagnation
Specialty Care segment revenue reached ₹603.2 Cr, contributing 34% of total revenue
Fatty Alcohol prices averaged $2,806/MT in Q1 FY27 compared to $2,751/MT in Q4 FY26
👀 What to Watch
Investors should monitor the sustainability of the high EBITDA/MT and the recovery in the AMET region (Egypt/West Asia) which is currently impacted by geopolitical disruptions.
108% PAT Growth: Galaxy Surfactants Reports Strong Q1 FY27 Results
Galaxy Surfactants reported a robust start to FY27, with consolidated revenue growing 39.4% YoY to ₹1,781.90 Cr. Net profit surged 108.7% YoY to ₹165.92 Cr, a significant recovery from the ₹79.49 Cr reported in the same quarter last year. The company also secured a favorable legal outcome as the Ankleshwar District Court quashed eviction proceedings regarding land valued at ₹72.67 Cr. Performance was bolstered by a strong contribution from a subsidiary which added ₹430.07 Cr to the top line.
Confidence: HIGH
What changedThe company has delivered a sharp turnaround in profitability and revenue growth compared to the relatively flat performance seen throughout FY26.
Why it mattersThe strong earnings beat suggests successful execution in Rest of World (ROW) markets and potential margin expansion, which is critical for a company trading at a P/E of 27.0.
Revenue (Q1 FY27): ₹1,781.90 CrPAT (Q1 FY27): ₹165.92 CrYoY Revenue Growth: 39.4%YoY PAT Growth: 108.7%GIDC Land Carrying Value: ₹72.67 CrQ1 Revenue vs TTM Revenue: ~34%
📅 Short termThe stock is likely to react positively in the short term due to the significant earnings surprise and the resolution of a key legal uncertainty regarding its manufacturing land.
📈 Long termIf the company maintains this growth trajectory in its specialty chemicals portfolio, it could lead to a structural re-rating of the business valuation over the next few years.
⚠ Risk flags
- Raw material price volatility (lag effect in passing costs)
- Geopolitical risks in the AMET region affecting Egypt operations
- Potential for GIDC to appeal the District Court's decision
Key Highlights
Consolidated Revenue from operations rose 39.4% YoY to ₹1,781.90 Cr from ₹1,277.92 Cr.
Consolidated Profit After Tax (PAT) increased 108.7% YoY to ₹165.92 Cr.
Quarterly Basic EPS jumped to ₹46.80 from ₹22.42 in the year-ago period.
Ankleshwar District Court quashed GIDC eviction proceedings for land with a carrying value of ₹72.67 Cr.
One subsidiary alone contributed ₹430.07 Cr in revenue and ₹47.84 Cr in PAT for the quarter.
👀 What to Watch
Investors should monitor the sustainability of these improved margins in upcoming quarters and track the volume growth in the 'Specialty Care' segment. Additionally, watch for any further appeals by GIDC regarding the Ankleshwar land matter.
Galaxy Surfactants Q4 FY26: India Volumes Up 8%, EBITDA at INR 122 Cr Amid Global Headwinds
Galaxy Surfactants reported a mixed Q4 FY26, with India showing resilience through 8% volume growth, while the AMET region faced a 15% decline due to geopolitical disruptions and logistics issues. EBITDA for the quarter stood at INR 122 crores, down from INR 135 crores YoY, with EBITDA per MT contracting to INR 20,114. Despite rising feedstock prices and supply chain challenges in Egypt, the company achieved a 27% annual growth in Specialty volumes. Management remains optimistic about sequential improvement, supported by a recovery in the US market following tariff reversals.
Key Highlights
India volume growth of 8% YoY, driven by a 27% surge in Specialty volumes and steady D2C demand.
AMET region volumes declined 15% YoY due to Red Sea disruptions and raw material availability constraints.
Q4 EBITDA per metric ton decreased to INR 20,114 from INR 21,715 in the previous year.
US specialty pipeline reinitiated post-tariff reversals, leading to sequential volume improvement in the Americas.
Launched 'Galsoft Lumithic', a next-generation mild surfactant, targeting the high-growth baby and sensitive care segments.
👀 What to Watch
Investors should monitor the company's ability to manage the lag in passing through rising raw material costs and the stabilization of logistics in the AMET region. The strong traction in high-margin Specialty products in India and the US provides a positive long-term outlook despite near-term margin pressure.
Galaxy Surfactants Q4 FY26: PAT Drops 17.7% to ₹62.4 Cr Despite 14% Revenue Growth
Galaxy Surfactants reported a 14.1% YoY increase in Q4 revenue to ₹1,315 crore, but profitability was significantly impacted by geopolitical tensions in West Asia and supply chain disruptions. PAT for the quarter declined by 17.7% YoY to ₹62.4 crore, with EBITDA margins contracting to 9.3% from 11.7% in the previous year. While the India market showed resilience with high single-digit volume growth, international markets like AMET and ROW faced volume declines due to logistics constraints. The company's specialty care segment remained a bright spot, growing by high single-digits despite the overall flat volume performance.
Key Highlights
Q4 Revenue grew 14.1% YoY to ₹1,315 crore, while FY26 revenue rose 24% to ₹5,270.4 crore.
Q4 PAT declined 17.7% YoY to ₹62.4 crore; FY26 PAT fell 12.3% to ₹267.4 crore.
EBITDA per MT for Q4 decreased to ₹20,113 from ₹21,715 in the corresponding period last year.
India volumes grew by high single-digits, but AMET region witnessed a mid-teens YoY decline in Q4.
Specialty Care products saw high single-digit growth in Q4, whereas Performance Surfactants declined by high single-digits.
👀 What to Watch
Investors should monitor the recovery in the AMET region and the stabilization of logistics costs, as geopolitical risks continue to pressure margins. The resilience in the Indian market and growth in specialty products are positive, but the overall bottom-line decline warrants a cautious approach.
Galaxy Surfactants Q4 FY26: Revenue Grows 14% YoY, but PAT Declines 17.7% Amid Margin Pressure
Galaxy Surfactants reported a 14.1% YoY increase in Q4FY26 consolidated revenue to ₹1,315 crore, driven by strong performance in India and the Specialty Care segment. However, consolidated PAT for the quarter fell 17.7% YoY to ₹62.4 crore as EBITDA margins compressed from 11.7% to 9.3% due to geopolitical disruptions in the AMET region and rising logistics costs. For the full year FY26, revenue stood at ₹5,270.4 crore, up 24% YoY, while EBITDA/MT slightly decreased to ₹19,357. Management remains optimistic about sequential improvements despite ongoing supply chain challenges in West Asia.
Key Highlights
Q4FY26 Consolidated Revenue rose 14.1% YoY to ₹1,315 crore, while FY26 Revenue grew 24% to ₹5,270.4 crore.
Consolidated PAT for Q4FY26 declined 17.7% YoY to ₹62.4 crore, impacted by higher input and logistics costs.
Specialty Care segment showed resilience with high single-digit volume growth in Q4, offsetting a high single-digit decline in Performance Surfactants.
India volumes grew by high single digits in Q4, while AMET volumes declined in the mid-teens due to West Asia geopolitical conflicts.
EBITDA per Metric Ton (MT) for Q4FY26 stood at ₹20,113 compared to ₹21,715 in the previous year's corresponding quarter.
👀 What to Watch
Investors should monitor the stabilization of margins and volume recovery in the AMET region, which has been hit by geopolitical issues. While the shift toward high-margin specialty products is a positive long-term driver, near-term volatility in raw material prices (Fatty Alcohol) and freight costs suggests a wait-and-watch approach.
Galaxy Surfactants FY26 Revenue Up 19.6% to ₹3,589 Cr; Recommends ₹22 Final Dividend
Galaxy Surfactants reported a robust 19.6% year-on-year growth in standalone revenue, reaching ₹3,589.07 crore for the full year ended March 31, 2026. The company's Q4FY26 revenue also saw a healthy increase to ₹928.34 crore from ₹814.25 crore in the previous year's quarter. A final dividend of ₹22 per share has been recommended, signaling management's confidence in cash flows. The audit report was clean with an unmodified opinion, ensuring financial transparency.
Key Highlights
Annual standalone revenue from operations rose to ₹3,589.07 crore in FY26 from ₹3,001.27 crore in FY25.
Board recommended a final dividend of ₹22 per equity share of face value ₹10.
Q4FY26 revenue stood at ₹928.34 crore, representing a 14% increase over Q4FY25.
Total annual income reached ₹3,618.70 crore compared to ₹3,027.72 crore in the previous fiscal.
Cost of materials consumed for the full year stood at ₹2,802.19 crore versus ₹2,188.85 crore in FY25.
👀 What to Watch
The strong top-line growth and healthy dividend payout make this a positive update for shareholders. Investors should monitor the impact of rising raw material costs on operating margins in the upcoming earnings call.
Galaxy Surfactants Recommends Final Dividend of Rs. 22 per Share for FY26
Galaxy Surfactants has recommended a final dividend of Rs. 22 per equity share for the financial year ended March 31, 2026. The company reported a robust increase in standalone revenue from operations, which rose to Rs. 3,589.07 Crores in FY26 from Rs. 3,001.27 Crores in the previous fiscal year. Total standalone income for the year reached Rs. 3,618.70 Crores, supported by a strong Q4 performance where income hit Rs. 934.51 Crores. The dividend is subject to approval at the upcoming Annual General Meeting scheduled for August 12, 2026.
Key Highlights
Recommended a final dividend of Rs. 22 per equity share (220% of face value).
Standalone revenue from operations grew by 19.6% YoY to Rs. 3,589.07 Crores.
Standalone total income for Q4 FY26 stood at Rs. 934.51 Crores versus Rs. 820.94 Crores in Q4 FY25.
The 40th Annual General Meeting is scheduled for August 12, 2026.
Statutory auditors issued an unmodified opinion on the annual audited financial results.
👀 What to Watch
Investors should monitor the record date for the Rs. 22 dividend to ensure eligibility. The steady growth in revenue suggests healthy business momentum, making it a positive signal for long-term shareholders.
Galaxy Surfactants FY26 Revenue Grows 19.6% to ₹3,589 Cr; Recommends ₹22 Final Dividend
Galaxy Surfactants reported a strong performance for the financial year ended March 31, 2026, with standalone revenue from operations rising to ₹3,589.07 crore from ₹3,001.27 crore in the previous year. The company's Q4 FY26 revenue also showed healthy growth, reaching ₹928.34 crore compared to ₹814.25 crore in the same quarter last year. In a move to reward shareholders, the Board has recommended a final dividend of ₹22 per equity share. The statutory auditors have issued an unmodified opinion on the financial results, confirming the reliability of the reported figures.
Key Highlights
Standalone annual revenue from operations increased by 19.6% YoY to ₹3,589.07 crore
Q4 FY26 standalone revenue grew by 14% YoY to ₹928.34 crore
Board recommended a final dividend of ₹22 per equity share of face value ₹10
Total income for the full year reached ₹3,618.70 crore versus ₹3,027.72 crore in FY25
Statutory auditors issued an unmodified opinion on both standalone and consolidated results
👀 What to Watch
Investors should take note of the consistent double-digit revenue growth and the healthy dividend payout as signs of strong operational health. The stock remains a solid pick for those seeking exposure to the specialty chemicals sector with steady returns.
Galaxy Surfactants Q3 EBITDA Rises 13% to INR 124 Cr; US Tariffs Slashed to 18%
Galaxy Surfactants reported a 13% YoY increase in Q3 FY26 EBITDA to INR 124 crores, with EBITDA per metric ton improving to INR 20,156. While consolidated volumes remained stable, the Specialty segment showed resilience with high single-digit growth, offsetting a decline in Performance Surfactants. A major structural positive is the reduction of U.S. reciprocal tariffs on Indian exports from 50% to 18%, which is expected to boost North American volumes. Management expects a recovery in the AMET region and India performance volumes starting Q4 FY26.
Key Highlights
Q3 FY26 EBITDA increased 13% YoY to INR 124 crores with EBITDA per MT rising to INR 20,156.
Reciprocal tariffs on Indian exports to the U.S. reduced from 50% to 18%, aiding specialty segment competitiveness.
India specialty business volume grew by over 35% YoY, despite overall domestic volume growth of mid-single digits.
Recognized a one-time exceptional charge of INR 11.9 crores related to the new labor code provisions.
Launched 5 new second-generation Sun Care products (GalSORB range) for commercialization in Q4 FY26.
👀 What to Watch
Investors should focus on the margin expansion potential from the reduced U.S. tariffs and the ramp-up of new specialty products. The stock remains a recovery play as AMET volumes stabilize and high-margin specialty mix increases.
Galaxy Surfactants Q3 Results: Revenue Up 27.6% to ₹1,334 Cr, PAT Declines 8.8% to ₹59 Cr
Galaxy Surfactants reported a strong 27.6% YoY revenue growth in Q3FY26, reaching ₹1,334.3 crore, primarily driven by a robust performance in the Specialty Care segment. However, PAT declined by 8.8% YoY to ₹59 crore, impacted by a ₹11.9 crore statutory charge related to new labor codes and margin compression. While India and ROW regions showed resilience with mid-single-digit volume growth, the AMET region faced a significant high double-digit volume decline due to competitive intensity. The company's EBITDA/MT improved to ₹20,156, reflecting a better product mix despite flat overall volumes.
Key Highlights
Revenue grew 27.6% YoY to ₹1,334.3 crore, while EBITDA rose 13.3% to ₹124.2 crore.
PAT decreased by 8.8% YoY to ₹59.0 crore, affected by a ₹11.9 crore exceptional item for labor codes.
Specialty Care segment in India delivered a robust 35% YoY volume growth, offsetting softness in performance surfactants.
AMET region volumes saw a high double-digit decline due to heightened competition, while ROW grew in mid-single digits.
EBITDA per Metric Ton (MT) improved to ₹20,156, supported by a favorable product mix and cost management.
👀 What to Watch
Investors should monitor the recovery in the AMET region and the impact of US tariff revisions on specialty exports. While the specialty segment shows strong momentum, the decline in bottom-line profitability and flat overall volumes warrant a cautious outlook until margins stabilize.
Galaxy Surfactants Q3FY26: EBITDA Up 13% YoY to ₹124 Cr; Specialty Care Volumes Grow 35% in India
Galaxy Surfactants reported a 27.6% YoY increase in revenue to ₹1,334.3 crore for Q3FY26, despite consolidated volumes remaining flat. EBITDA grew 13.3% YoY to ₹124.2 crore, with EBITDA per MT improving to ₹20,156 due to a favorable product mix and disciplined cost management. PAT declined by 8.8% YoY to ₹59 crore, primarily impacted by a one-time exceptional charge of ₹11.9 crore related to new labor codes. While the AMET region faced a high-teen volume decline due to competition, the Indian specialty segment showed robust 35% growth.
Key Highlights
Revenue increased 27.6% YoY to ₹1,334.3 crore, while EBITDA rose 13.3% to ₹124.2 crore.
EBITDA per MT improved to ₹20,156 from ₹17,527 in Q3FY25, reflecting better margin realization.
Specialty Care segment in India delivered 35% YoY volume growth, cushioning softness in Tier-1 accounts.
AMET region volumes declined in the high teens YoY due to intensified local competition.
PAT of ₹59 crore was impacted by a ₹11.9 crore exceptional item for statutory impact of new labor codes.
👀 What to Watch
Investors should monitor the recovery in the AMET region and the impact of US tariff revisions on exports. The continued shift towards high-margin specialty products and improved EBITDA/MT are positive indicators for long-term margin sustainability.
Galaxy Surfactants Q3 Revenue Rises 27.6% YoY to ₹1,329 Cr; PAT Dips to ₹59 Cr on Exceptional Costs
Galaxy Surfactants reported a strong 27.6% YoY growth in consolidated revenue for Q3 FY26, reaching ₹1,329.49 crore. However, Profit After Tax (PAT) declined by 8.7% YoY to ₹58.97 crore, primarily impacted by an exceptional charge of ₹11.88 crore related to the implementation of new Labour Codes. On a nine-month basis, revenue grew significantly by 27.8% to ₹3,933.58 crore, though PAT remained lower at ₹204.95 crore compared to ₹229.04 crore in the previous year. The company is also managing a legal dispute regarding land in Gujarat with a carrying value of ₹73.10 crore, currently under interim stay.
Key Highlights
Consolidated Revenue from operations grew 27.6% YoY to ₹1,329.49 crore in Q3 FY26.
Net Profit (PAT) for the quarter stood at ₹58.97 crore, down from ₹64.61 crore in the same period last year.
An exceptional item of ₹11.88 crore was recorded due to the notification of new Labour Codes affecting employee benefits.
Cost of materials consumed rose sharply to ₹954.45 crore in Q3 FY26 from ₹744.03 crore in Q3 FY25.
Nine-month revenue reached ₹3,933.58 crore, showing robust top-line momentum despite bottom-line pressure.
👀 What to Watch
Investors should monitor the impact of rising raw material costs on margins, as strong top-line growth is currently being offset by higher expenses and exceptional items. The resolution of the GIDC land dispute remains a key monitorable for long-term asset security.
